<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
    <journal-id journal-id-type="iso-abbrev">PeerJ</journal-id>
    <journal-id journal-id-type="pmc">PeerJ</journal-id>
    <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
    <journal-title-group>
      <journal-title>PeerJ</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2167-8359</issn>
    <publisher>
      <publisher-name>PeerJ Inc.</publisher-name>
      <publisher-loc>San Diego, USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7246032</article-id>
    <article-id pub-id-type="publisher-id">9119</article-id>
    <article-id pub-id-type="doi">10.7717/peerj.9119</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Bioinformatics</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Biology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Dermatology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Computational Science</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>VIRdb: a comprehensive database for interactive analysis of genes/proteins involved in the pathogenesis of vitiligo</article-title>
    </title-group>
    <contrib-group>
      <contrib id="author-1" contrib-type="author">
        <name>
          <surname>Srivastava</surname>
          <given-names>Priyansh</given-names>
        </name>
      </contrib>
      <contrib id="author-2" contrib-type="author">
        <name>
          <surname>Choudhury</surname>
          <given-names>Alakto</given-names>
        </name>
      </contrib>
      <contrib id="author-3" contrib-type="author">
        <name>
          <surname>Talwar</surname>
          <given-names>Mehak</given-names>
        </name>
      </contrib>
      <contrib id="author-4" contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7099-5750</contrib-id>
        <name>
          <surname>Mohanty</surname>
          <given-names>Sabyasachi</given-names>
        </name>
      </contrib>
      <contrib id="author-5" contrib-type="author" corresp="yes">
        <name>
          <surname>Narad</surname>
          <given-names>Priyanka</given-names>
        </name>
        <email>pnarad@amity.edu</email>
      </contrib>
      <contrib id="author-6" contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3958-3675</contrib-id>
        <name>
          <surname>Sengupta</surname>
          <given-names>Abhishek</given-names>
        </name>
        <email>asengupta@amity.edu</email>
      </contrib>
      <aff><institution>Amity Institute of Biotechnology, Amity University, Uttar Pradesh</institution>, <country>India</country></aff>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Uversky</surname>
          <given-names>Vladimir</given-names>
        </name>
      </contrib>
    </contrib-group>
    <pub-date pub-type="epub" date-type="pub" iso-8601-date="2020-05-21">
      <day>21</day>
      <month>5</month>
      <year iso-8601-date="2020">2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>8</volume>
    <elocation-id>e9119</elocation-id>
    <history>
      <date date-type="received" iso-8601-date="2020-01-02">
        <day>2</day>
        <month>1</month>
        <year iso-8601-date="2020">2020</year>
      </date>
      <date date-type="accepted" iso-8601-date="2020-04-13">
        <day>13</day>
        <month>4</month>
        <year iso-8601-date="2020">2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2020 Srivastava et al.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <copyright-holder>Srivastava et al.</copyright-holder>
      <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="https://peerj.com/articles/9119"/>
    <abstract>
      <p>Vitiligo is a chronic asymptomatic disorder affecting melanocytes from the basal layer of the epidermis which leads to a patchy loss of skin color. Even though it is one of the neglected disease conditions, people suffering from vitiligo are more prone to psychological disorders. As of now, various studies have been done in order to project auto-immune implications as the root cause. To understand the complexity of vitiligo, we propose the Vitiligo Information Resource (VIRdb) that integrates both the drug-target and systems approach to produce a comprehensive repository entirely devoted to vitiligo, along with curated information at both protein level and gene level along with potential therapeutics leads. These 25,041 natural compounds are curated from Natural Product Activity and Species Source Database. VIRdb is an attempt to accelerate the drug discovery process and laboratory trials for vitiligo through the computationally derived potential drugs. It is an exhaustive resource consisting of 129 differentially expressed genes, which are validated through gene ontology and pathway enrichment analysis. We also report 22 genes through enrichment analysis which are involved in the regulation of epithelial cell differentiation. At the protein level, 40 curated protein target molecules along with their natural hits that are derived through virtual screening. We also demonstrate the utility of the VIRdb by exploring the Protein–Protein Interaction Network and Gene–Gene Interaction Network of the target proteins and differentially expressed genes. For maintaining the quality and standard of the data in the VIRdb, the gold standard in bioinformatics toolkits like Cytoscape, Schrödinger’s GLIDE, along with the server installation of MATLAB, are used for generating results. VIRdb can be accessed through “<uri xlink:href="http://www.vitiligoinfores.com/">http://www.vitiligoinfores.com/</uri>”.</p>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Vitiligo</kwd>
      <kwd>Database</kwd>
      <kwd>Differential genes</kwd>
      <kwd>Protein targets</kwd>
      <kwd>Molecular docking</kwd>
      <kwd>Natural compounds</kwd>
    </kwd-group>
    <funding-group>
      <funding-statement>The authors received no funding for this work.</funding-statement>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Vitiligo is a chronic asymptomatic disorder affecting melanocytes from the basal layer of the epidermis which leads to a patchy loss of skin color (<xref rid="ref-23" ref-type="bibr">Rodrigues et al., 2017</xref>). It affects 0.5–2% of the world’s population (<xref rid="ref-9" ref-type="bibr">Ezzedine &amp; Silverberg, 2016</xref>). The lesions can appear in different shapes and sizes on any visible part of the body (<xref rid="ref-33" ref-type="bibr">Tarlé et al., 2014</xref>). Even though it is one of the neglected diseases condition people suffering from vitiligo are more prone to psychological disorders and the risk of developing hearing problems (<xref rid="ref-8" ref-type="bibr">Ezzedine et al., 2015</xref>). The auto-immune inflammation theory remains to be the most acceptable, accounting for its development via an adaptive immune response (<xref rid="ref-4" ref-type="bibr">Boniface et al., 2017</xref>). According to biochemical theory, accumulation of Reactive Oxygen species (ROS) in the melanocytes remains the pioneer, for activation of CD8+ T cells against melanocytes (<xref rid="ref-36" ref-type="bibr">Wang, Li &amp; Li, 2019</xref>; <xref rid="ref-7" ref-type="bibr">Deng et al., 2019</xref>). Previous studies have also reported that HIF-1-alpha, F2RL-1 and PIK3CB over-expression in CD8+ cells (<xref rid="ref-7" ref-type="bibr">Deng et al., 2019</xref>). HIF-1-alpha plays a crucial part in ROS accumulation response, whereas the F2RL-1 and PIK3CB are responsible for an immune response with CD8+ T cells (<xref rid="ref-7" ref-type="bibr">Deng et al., 2019</xref>). Due to loss of melanocytes in individuals affected by vitiligo, one can also expect an increased incidence of non-melanoma cancer and actinic keratose (<xref rid="ref-42" ref-type="bibr">Zhang et al., 2016</xref>). Arresting the progression of lesions and repigmentation of formed lesions remains to be a crucial strategy for treatment (<xref rid="ref-3" ref-type="bibr">Bishnoi &amp; Parsad, 2018</xref>). AK-STAT inhibitors have demonstrated promising outcomes in the treatment of vitiligo, including repigmentation in topical applications. JAK inhibitor, tofacitinib and JAK-1,2 inhibitor, ruxolitinib, have been tested positive in causing repigmentation (<xref rid="ref-3" ref-type="bibr">Bishnoi &amp; Parsad, 2018</xref>).</p>
    <p>To understand the complexity of the vitiligo, we envisage a comprehensive online repository focusing on the systematically derived and manually curated potential protein targets along with their prospective hits derived from the natural compounds databases. To fully understand the genetic complexity of the vitiligo we also aim to present a genetic interaction network of the differentially expressed genes, in Lesional Vitiligo, Peri-Lesional Vitiligo, and Non-Lesional Vitiligo against healthy controls. The predicted differentially expressed genes across samples were then validated using gene enrichment analysis with Kyoto Encyclopedia of Gene and Genome (KEGG) and Gene Ontology (GO) (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>; <xref rid="ref-34" ref-type="bibr">The Gene Ontology Consortium, 2007</xref>). The Vitiligo Information Resource (VIRdb) systematically harbors all the information relating to vitiligo in terms of Potential protein targets and differentially expressed genes in a user-friendly database. As more than 50% of the approved drugs in DrugBank are natural compounds, therefore, we took the liberty of virtually screening all the natural compounds present in Natural Product Activity and Species Source Database (NPASS) against the potential protein targets (<xref rid="ref-37" ref-type="bibr">Wishart et al., 2017</xref>; <xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). For maintaining, the quality and standard of the data in the VIRdb, the gold standard in bioinformatics toolkits like Cytoscape, Schrödinger’s GLIDE, along with the server installation of MATLAB are used (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>; <xref rid="ref-26" ref-type="bibr">Schrödinger, 2020</xref>; <xref rid="ref-18" ref-type="bibr">MATLAB, 2019</xref>). The screened library can be used to carry wet-lab experiments based on potential hits which would thereby lead to considerably less consumption of time and other resources to carry out the protocol for drug development. We envision that VIRdb will be pertinent for the researchers and clinicians engaged in drug development for vitiligo.</p>
  </sec>
  <sec sec-type="methods">
    <title>Methods</title>
    <sec>
      <title>Microarray gene expression analysis</title>
      <p>Gene Expression Omnibus was manually queried using “(“vitiligo” (MeSH Terms) OR vitiligo (All Fields)) AND (“humans” (MeSH Terms) OR “<italic>Homo sapiens</italic>” (Organism) OR homo sapiens (All Fields))”. The returned results were manually curated for microarray experiments having healthy controls against affected individuals. We selected <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65127">GSE65127</uri> as it comprises of 10 healthy controls against 10 conditions (Lesional, Peri-lesional, Non-lesional). The CEL files of 40 samples having expression data of Lesional, Peri-lesional, Non-lesional against healthy control on Affymetrix GPL570 platform were isolated (<xref rid="ref-6" ref-type="bibr">Clough &amp; Barrett, 2016</xref>; <xref rid="ref-22" ref-type="bibr">Regazzetti et al., 2015</xref>) data. Combinations of {Healthy vs (Lesional, Peri-lesional, Non-lesional)} were processed using the server installation of <xref rid="ref-18" ref-type="bibr">MATLAB (2019)</xref> by applying the GC Robust Multichip Averaging (GCRMA) method with Empirical Bayes (<xref rid="ref-18" ref-type="bibr">MATLAB, 2019</xref>; <xref rid="ref-39" ref-type="bibr">Wu et al., 2004</xref>). GCRMA empirical Bayes is the posterior mean estimate which is calculated through <italic>S</italic>, that represents a quantity proportional to the concentration of transcripts in the hybridization mixture (<xref ref-type="disp-formula" rid="eqn-1">Eq. 1</xref>). After the raw reads from CEL files are converted to expression data through GCRMA, the probe sets with un-annotated gene symbols were dropped programmatically. A <italic>t</italic>-test is performed with each gene expression value to study the relevant changes in the expression values. False Discovery Rate (FDR) for each test situation was computed using Storey–Tibshirani procedure (<xref rid="ref-29" ref-type="bibr">Storey &amp; Tibshirani, 2003</xref>). To compute the biological expression significance, −log10 of <italic>p</italic>-values was calculated and plotted against log fold change (2 folds).</p>
      <disp-formula id="eqn-1">
        <label>(1)</label>
        <alternatives>
          <graphic xlink:href="peerj-08-9119-e001.jpg" mimetype="image" mime-subtype="png" position="float" orientation="portrait"/>
          <tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$s = E\left[ {s|S \gt 0,{\rm PM},{\rm MM}} \right], \quad \; {\rm with}\ s = {\rm log}\left( S \right)$$\end{document}</tex-math>
          <mml:math id="mml-eqn-1">
            <mml:mi>s</mml:mi>
            <mml:mo>=</mml:mo>
            <mml:mi>E</mml:mi>
            <mml:mrow>
              <mml:mo>[</mml:mo>
              <mml:mrow>
                <mml:mi>s</mml:mi>
                <mml:mrow>
                  <mml:mo stretchy="false">|</mml:mo>
                </mml:mrow>
                <mml:mi>S</mml:mi>
                <mml:mo>&gt;</mml:mo>
                <mml:mn>0</mml:mn>
                <mml:mo>,</mml:mo>
                <mml:mrow>
                  <mml:mi mathvariant="normal">P</mml:mi>
                  <mml:mi mathvariant="normal">M</mml:mi>
                </mml:mrow>
                <mml:mo>,</mml:mo>
                <mml:mrow>
                  <mml:mi mathvariant="normal">M</mml:mi>
                  <mml:mi mathvariant="normal">M</mml:mi>
                </mml:mrow>
              </mml:mrow>
              <mml:mo>]</mml:mo>
            </mml:mrow>
            <mml:mo>,</mml:mo>
            <mml:mspace width="1em"/>
            <mml:mspace width="thickmathspace"/>
            <mml:mrow>
              <mml:mi mathvariant="normal">w</mml:mi>
              <mml:mi mathvariant="normal">i</mml:mi>
              <mml:mi mathvariant="normal">t</mml:mi>
              <mml:mi mathvariant="normal">h</mml:mi>
            </mml:mrow>
            <mml:mspace width="0.25em"/>
            <mml:mi>s</mml:mi>
            <mml:mo>=</mml:mo>
            <mml:mrow>
              <mml:mi mathvariant="normal">l</mml:mi>
              <mml:mi mathvariant="normal">o</mml:mi>
              <mml:mi mathvariant="normal">g</mml:mi>
            </mml:mrow>
            <mml:mrow>
              <mml:mo>(</mml:mo>
              <mml:mi>S</mml:mi>
              <mml:mo>)</mml:mo>
            </mml:mrow>
          </mml:math>
        </alternatives>
      </disp-formula>
    </sec>
    <sec>
      <title>Gene–gene interaction network construction</title>
      <p>For designing the gene–gene interaction network for differentially expressed genes, GeneMania plugin from Cytoscape was used (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>; <xref rid="ref-20" ref-type="bibr">Mostafavi et al., 2020</xref>). Initially, 3 distinct networks for differentially expressed genes (Expressed in lesional, Expressed in non-lesional, and Expressed in peri-lesional) were made. After that, all the networks are merged, with common interacting gene nodes in the Cytoscape environment (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>). The tangential nodes were manually deleted and only the highly connected nodes were taken for further analysis. The predicted co-expressed genes from GeneMania interaction network were also taken for enrichment analysis (<xref rid="ref-20" ref-type="bibr">Mostafavi et al., 2020</xref>).</p>
    </sec>
    <sec>
      <title>Gene Ontology (GO) and pathway analysis</title>
      <p>ShinyGO server was used for the pathway enrichment analysis of the single expression conditions (Lesional, Peri-Lesional and Non-lesional, each distinctly) and unique differentially expressed genes (significant expression at least once across the conditions) and predicted GGI genes from GeneMania (<xref rid="ref-20" ref-type="bibr">Mostafavi et al., 2020</xref>; <xref rid="ref-10" ref-type="bibr">Ge, Jung &amp; Yao, 2019</xref>). The differentially expressed genes were enriched in Kyoto Encyclopedia of Gene and Genome database (KEGG) (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>). The false discovery rate of 0.01 was used as the cut off to elute out the most significant pathways. For GO enrichment analysis the GO database was recruited from the ShinyGO server and GO enrichment analysis was functioned with the false discovery rate of &lt;0.01 (<xref rid="ref-34" ref-type="bibr">The Gene Ontology Consortium, 2007</xref>; <xref rid="ref-20" ref-type="bibr">Mostafavi et al., 2020</xref>).</p>
    </sec>
    <sec>
      <title>Biological data collection</title>
      <p>The Pubmed Engine was queried using “((Vitiligo) AND (Proteins)) AND (Protein–Protein Interaction)” for retrieval of literature relating to the protein targets (<xref rid="ref-21" ref-type="bibr">Motschall &amp; Falck-Ytter, 2005</xref>). The query returned 4 abstracts, out of which study that includes the systemic approach for the construction of Protein–Protein Interaction Network (PPI) was taken into consideration (<xref rid="ref-16" ref-type="bibr">Malhotra et al., 2017</xref>). PPI network of 215 proteins was revitalized using Cytoscape 3.7 and String Database (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>; <xref rid="ref-19" ref-type="bibr">Mering, 2003</xref>; <xref rid="ref-16" ref-type="bibr">Malhotra et al., 2017</xref>). A total of 50 protein targets were eluted out of the set of reported 64 vitiligo core proteins in the study (<xref rid="ref-16" ref-type="bibr">Malhotra et al., 2017</xref>). The sub-network of 50 proteins was created manually based on coherence of centrality among 64 nodes (<xref rid="ref-16" ref-type="bibr">Malhotra et al., 2017</xref>). Finally considering the on the availability of X-ray crystallographic structures in Protein Data Bank 40 protein crystal structures were taken for molecular docking out of 50 nodes (<xref ref-type="supplementary-material" rid="supp-1">Appendix I</xref>) (<xref rid="ref-2" ref-type="bibr">Berman, 2000</xref>; <xref rid="ref-16" ref-type="bibr">Malhotra et al., 2017</xref>). All the potential protein targets were annotated manually with their respective UniProt ID, PDB ID, STRING ID, KEGG ID, encoding Gene Symbol and target active amino acids from the scientific literature (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>; <xref rid="ref-19" ref-type="bibr">Mering, 2003</xref>; <xref rid="ref-2" ref-type="bibr">Berman, 2000</xref>; <xref rid="ref-35" ref-type="bibr">The UniProt Consortium, 2016</xref>). Highest-resolution structures were manually curated and confiscated for Molecular docking studies for the protein structures that comprises multiple deposits in the Protein Data Bank (<xref rid="ref-38" ref-type="bibr">Wlodawer et al., 2013</xref>). For identification of the active amino acids, each PDB profile was manually curated in reference to its literature (<xref ref-type="supplementary-material" rid="supp-1">Appendix I</xref>).</p>
    </sec>
    <sec>
      <title>Virtual screening against NPASS</title>
      <p>As more than 50% of the approved drugs in DrugBank are natural compounds, therefore, we took the liberty of virtually screening all the natural compounds present in Natural Product Activity and Species Source Database (NPASS) against the potential protein targets (<xref rid="ref-37" ref-type="bibr">Wishart et al., 2017</xref>; <xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). The NPASS database consists of 25,041 natural compounds (<xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). Every structure was neutralized at the physiological pH and a library of 36,229 potential ligands was created including the stereoisomers and tautomers (<xref rid="ref-28" ref-type="bibr">Srivastava, Pal &amp; Misra, 2018</xref>). Target protein structures files were prepared using Schrödinger Protein Preparation Wizard by removing excess waters and were minimized using OPLS 2005 force field (<xref rid="ref-5" ref-type="bibr">Clark et al., 2019</xref>; <xref rid="ref-31" ref-type="bibr">Sweere &amp; Fraaije, 2017</xref>). Receptor grid of dimensions of 15 × 15 × 15 angstroms was generated around the active amino acids. Glide HTVS pipeline was used to carry out virtual screening of the natural compound library to each target protein. Ligands were sorted and ranked based on the Glide score as it is empirical of various computed scores and is also quite accurate in wet-lab experimentation (<xref rid="ref-11" ref-type="bibr">Greenwood et al., 2010</xref>).</p>
    </sec>
    <sec>
      <title>Architecture and design</title>
      <p>Vitiligo Information Resource was formulated using Apache HTTP server on Linux Platform. MySQL was used to store the information as it offers fast and easy query processing because of its RDBMS architecture (<xref rid="ref-17" ref-type="bibr">Mathur et al., 2016</xref>). HTML 5 and Cascading Style Sheets were used to design the front-end interface of the VIRdb. PHP 7 was used for maintaining the dynamic connectivity between the front-end and back-end. Each entry in the database was connected to their parent database via html anchors. The complete architectural schema of vitiligo information resource db is depicted in <xref ref-type="fig" rid="fig-1">Fig. 1</xref>.</p>
      <fig id="fig-1" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.9119/fig-1</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Database architecture.</title>
          <p>Architecture of VIR database.</p>
        </caption>
        <graphic xlink:href="peerj-08-9119-g001"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <sec>
      <title>Differentially expressed genes</title>
      <p>A total of 123 differential genes for lesional vitiligo against healthy controls. Out of 123 genes, 52 genes were predicted to be as under-expressed and 70 genes were predicted to be over-expressed in accordance with the LogFc filter (<xref ref-type="supplementary-material" rid="supp-2">Appendix II</xref>; <xref ref-type="fig" rid="fig-2">Fig. 2A</xref>). In the case of Non-Lesional vs healthy control, a total of 27 upregulated differential genes were identified (<xref ref-type="supplementary-material" rid="supp-3">Appendix III</xref>; <xref ref-type="fig" rid="fig-2">Fig. 2B</xref>). For Peri-Lesional vitiligo, a total of 32 upregulated genes were curated (<xref ref-type="supplementary-material" rid="supp-4">Appendix IV</xref>; <xref ref-type="fig" rid="fig-2">Fig. 2C</xref>). Upon, a union of all the sets (Differential Genes, Lesional, Non-Lesional, and Peri-Lesional) as a total of 129 differential genes have been curated. Out of which 52 were under-expressed and 76 were over-expressed (<xref ref-type="supplementary-material" rid="supp-5">Appendix V</xref>).</p>
      <fig id="fig-2" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.9119/fig-2</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Heatmap for lesional, non-lesional and peri-lesional conditions.</title>
          <p>Heatmap of differentially expressed gene expression values with black bars representing the Healthy/control samples and red being the case/diseased samples; (A) heatmap of differentially expressed gene expression values in lesional vitiligo against Healthy controls; (B) heatmap of differentially expressed gene expression values in non-lesional vitiligo against healthy controls; (C) heatmap of differentially expressed gene expression values in peri-lesional vitiligo against healthy controls.</p>
        </caption>
        <graphic xlink:href="peerj-08-9119-g002"/>
      </fig>
    </sec>
    <sec>
      <title>GO and pathway enrichment analysis</title>
      <p>The DCT, EDNRB, TYR, TYRP1, and WNT6 that were from the set of 129 unique differentially expressed genes across the samples were enriched in Melanogenesis pathway with an FDR of 0.0038 in KEGG (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>) (<xref ref-type="supplementary-material" rid="supp-6">Appendix VI</xref>). Upon GO enrichment 6 genes (GPR143, OCA2, TYR, DCT, TYRP1, SLC45A2) were enriched in Melanosome membrane (Cellular Compartment), 7 genes (TYR, DCT, TYRP1, OCA2, SLC45A2, PMEL, CDH3) were enriched in Melanin metabolic process (Biological Process) (<xref rid="ref-34" ref-type="bibr">The Gene Ontology Consortium, 2007</xref>) (<xref ref-type="supplementary-material" rid="supp-7">Appendix VII</xref>). Surprisingly, 2 genes were enriched with monophenol monooxygenase activity (molecular function) and 2 genes were enriched in oxidoreductase activity (molecular function), which could account for the oxidative stress-induced melanocyte degradation (<xref rid="ref-36" ref-type="bibr">Wang, Li &amp; Li, 2019</xref>; <xref rid="ref-7" ref-type="bibr">Deng et al., 2019</xref>) (<xref ref-type="supplementary-material" rid="supp-7">Appendix VII</xref>) (For enrichment analysis of the single expression conditions (Lesional, Peri-Lesional and Non-lesional, each distinctly) see <xref ref-type="supplementary-material" rid="supp-9">Supplements 1</xref>–<xref ref-type="supplementary-material" rid="supp-11">3</xref>).</p>
    </sec>
    <sec>
      <title>Gene–gene interaction network</title>
      <p>We upvote 22 genes that were predicted while construction of common network (ACYP1, APLP2, ARNTL, CEBPG, CPEB2, DIP2A, HNRNPA3, HNRNPA3P1, HTATSF1, JKAMP, MAFG, MFN2, MKL1, ORC2, PAGR1, PDPK1, PEX5, PRKX, PRKY, TLE4, TMEM70, USP47) with GeneMania (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>, <xref ref-type="fig" rid="fig-3">Fig. 3</xref>; <xref ref-type="supplementary-material" rid="supp-8">Appendix VIII</xref>). Upon gene enrichment analysis of these 22 genes with GO db MAFG, PRKX, ARNTL were enriched in Regulation of epithelial cell differentiation as the biological process (<xref rid="ref-34" ref-type="bibr">The Gene Ontology Consortium, 2007</xref>). These genes were never reported in the literature for these types of vitiligo therefore, might be relevant in understanding the molecular aspects of vitiligo.</p>
      <fig id="fig-3" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.9119/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>GGI Network.</title>
          <p>Gene–gene Interaction network of the predicted set of differential genes in lesional, non-lesional, and peri-lesional condition through the set of 129 unique genes; co-expressed genes are shown in gray nodes; constructed using Cytoscape 3.7 (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>).</p>
        </caption>
        <graphic xlink:href="peerj-08-9119-g003"/>
      </fig>
    </sec>
    <sec>
      <title>Data browsing and web interface</title>
      <p>The main browsing window of the VIRdb holds the links to Target proteins, Potential hits and differential genes (<xref ref-type="fig" rid="fig-4">Fig. 4A</xref>). The end-user can either browse any of the sections or can directly download the data in CSV file format. The network files are only available for download and can be downloaded in SIF of the Cytoscape 3.7. The target protein toggle directs the user to the comprehensive list of proteins that were used as targets for the molecular docking studies (<xref rid="ref-27" ref-type="bibr">Shannon, 2003</xref>). The other two toggles of potential hits and differential genes direct the user towards the dynamic tables where the user can select from the types of vitiligo and target specific drugs. The target proteins have individual profiles as shown in <xref ref-type="fig" rid="fig-4">Fig. 4B</xref>, which comprises their active site residue references along with the potential hits against it. The identifiers (STRING ID, KEGG ID, PDB Id, SwissProt Id) of the target proteins are connected to their respective databases through the HTML anchors (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>; <xref rid="ref-19" ref-type="bibr">Mering, 2003</xref>; <xref rid="ref-2" ref-type="bibr">Berman, 2000</xref>; <xref rid="ref-35" ref-type="bibr">The UniProt Consortium, 2016</xref>). The encoding genes for the proteins are connected to the GeneCards database for maintaining the quality of data (<xref rid="ref-24" ref-type="bibr">Safran et al., 2010</xref>). The user can directly download the molecular docking results (NPASS ids, Docking Scores, Glide gscores, and Glide energy) in CSV file format from the individual protein profiles for further analysis (<xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). The active site reference of the protein is depicted in a tabular format depicting the amino residue name, chain and position in the sequence. Potential hits can be browsed through dynamic tables and frames. The user can select the protein’s PDB identifier from below the navigation pane and can dynamically see the tailored results for the potential hits against them. The tables contain information about the NPASS db identifier, Glide Gscore, Docking Score and Glide energy, that correlates to the binding affinity of the ligand with the target. Each NPASS identifier is connected to the NPASS db entry of the respective compound (<xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). The user can also download the results from this page in CSV files formats for further analysis. Differential genes that are predicted using <xref rid="ref-18" ref-type="bibr">MATLAB (2019)</xref> are also projected in a dynamic fashion. The end-user can see the genes by selecting the appropriate toggle from below the navigation bar. The table consists of Probe Ids, LogFc, Gene Symbol, Adjusted <italic>p</italic>-values and gene descriptions. Each gene symbol is connected to the GeneCard entry through HTML anchors (<xref rid="ref-24" ref-type="bibr">Safran et al., 2010</xref>). LogFc values with negative signs denote the downregulated genes while the positive ones account for the upregulation. The probe IDs of the genes are connected to Harvard’s Gene Enrichment Profiler (<xref rid="ref-1" ref-type="bibr">Bateman et al., 2014</xref>).</p>
      <fig id="fig-4" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.9119/fig-4</object-id>
        <label>Figure 4</label>
        <caption>
          <title>VIRdb Interface.</title>
          <p>(A) Browsing Interface of VIRdb and (B) individual protein profile.</p>
        </caption>
        <graphic xlink:href="peerj-08-9119-g004"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion and community impact</title>
      <p>As per the results of KEGG enrichment analysis, the differential genes were enriched in the pathway of Melanogenesis. WNT6 being one of the enriched genes has been previously reported for vitiligo therapeutics and wound healing through melanocyte stem cell differentiation (<xref rid="ref-40" ref-type="bibr">Yamada et al., 2013</xref>; <xref rid="ref-30" ref-type="bibr">Sun et al., 2018</xref>). Moreover, DCT, TYR, EDNRB and TYRP1 have also been reported previously playing a vital role in vitiligo (<xref rid="ref-25" ref-type="bibr">Salinas-Santander et al., 2018</xref>; <xref rid="ref-13" ref-type="bibr">Jin et al., 2010</xref>; <xref rid="ref-32" ref-type="bibr">Takeo et al., 2016</xref>). Therefore, other differential genes which were enriched along with WNT6, DCT, TYR, EDNRB and TYRP1 by GO could provide more insights on vitiligo prognosis (<xref ref-type="supplementary-material" rid="supp-7">Appendix VII</xref>). We also report ACYP1, APLP2, ARNTL, CEBPG, CPEB2, DIP2A, HNRNPA3, HNRNPA3P1, HTATSF1, JKAMP, MAFG, MFN2, MKL1, ORC2, PAGR1, PDPK1, PEX5, PRKX, PRKY, TLE4, TMEM70, USP47 for these types of vitiligo (Lesional, Non-lesional, and Peri-Lesional) therefore might be relevant in understanding the molecular aspects of vitiligo. VIRdb, integrates both drug-target and systems approach to produce a comprehensive repository entirely devoted to Vitiligo. Having curated information at both protein level and gene level along with potential therapeutics hits makes VIRdb first and one of its kind disease-specific databases in the scientific community. VIRdb holds manually curated protein targets that are involved in the vitiligo based on the systems approach, these protein target structure files are minimized and optimized using OPLS 2005 force fields and can be downloaded from the database for carrying out in-silico analysis. VIR also offers a complete profile for these target protein having links to all major databases (KEGG db, STRING db, GeneCards db, SwissProt db, NPASS db) making it a cross-functional database as well (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>; <xref rid="ref-19" ref-type="bibr">Mering, 2003</xref>; <xref rid="ref-35" ref-type="bibr">The UniProt Consortium, 2016</xref>; <xref rid="ref-24" ref-type="bibr">Safran et al., 2010</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions">
    <title>Conclusion</title>
    <p>Lesional Vitiligo, Peri-Lesional vitiligo, and Non-Lesional vitiligo being the most common types of vitiligo have been thoroughly studied for differentially expressed genes and are descriptively integrated into the compendium of VIRdb. All of which are validated through KEGG and GO db, having pathways in functions in melanogenesis (<xref rid="ref-14" ref-type="bibr">Kanehisa et al., 2020</xref>; <xref rid="ref-34" ref-type="bibr">The Gene Ontology Consortium, 2007</xref>). It is also the home for the potentially active natural compounds that are virtually screened against the potential protein targets. These compounds are curated from NPASS db (<xref rid="ref-41" ref-type="bibr">Zeng et al., 2017</xref>). It is an attempt to accelerate the drug discovery process and laboratory trials for vitiligo. We will update VIRdb iteratively at regular intervals in order to cover the domain of vitiligo as a diseased condition. We also provide users with an option to submit new data. Moreover, we will validate each new entry before its incorporation for maintaining a high level of quality of data. In future various improvizations on the VIRdb could be done like the inclusion of various other chemical databases like ZINC, DrugBank and PubChem (<xref rid="ref-37" ref-type="bibr">Wishart et al., 2017</xref>; <xref rid="ref-12" ref-type="bibr">Irwin &amp; Shoichet, 2005</xref>; <xref rid="ref-15" ref-type="bibr">Kim et al., 2015</xref>).</p>
  </sec>
  <sec sec-type="supplementary-material" id="supplemental-information">
    <title>Supplemental Information</title>
    <supplementary-material content-type="local-data" id="supp-1">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-1</object-id>
      <label>Supplemental Information 1</label>
      <caption>
        <title>Appendix 1.</title>
        <p>All protein Targets</p>
      </caption>
      <media xlink:href="peerj-08-9119-s001.xlsx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-2">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-2</object-id>
      <label>Supplemental Information 2</label>
      <caption>
        <title>Appendix 2.</title>
        <p>Differentially Expressed Genes for Lesional Vitiligio</p>
      </caption>
      <media xlink:href="peerj-08-9119-s002.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-3">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-3</object-id>
      <label>Supplemental Information 3</label>
      <caption>
        <title>Appendix 3.</title>
        <p>Differentially expressed genes for Non-Lesiional Vitiligo</p>
      </caption>
      <media xlink:href="peerj-08-9119-s003.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-4">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-4</object-id>
      <label>Supplemental Information 4</label>
      <caption>
        <title>Appendix 4.</title>
        <p>Diffferentially expressed genes for Peri-Lesional Vitiligo</p>
      </caption>
      <media xlink:href="peerj-08-9119-s004.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-5">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-5</object-id>
      <label>Supplemental Information 5</label>
      <caption>
        <title>Appendix 5.</title>
        <p>Union of Differentially Expressed gene across all 3 conditions (lesional, non-lesion, peri-lesional)</p>
      </caption>
      <media xlink:href="peerj-08-9119-s005.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-6">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-6</object-id>
      <label>Supplemental Information 6</label>
      <caption>
        <title>Appendix 6.</title>
        <p>KEGG enrichment analysis of the union of set of genes across 3 conditions (lesional, non-lesion, peri-lesional)</p>
      </caption>
      <media xlink:href="peerj-08-9119-s006.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-7">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-7</object-id>
      <label>Supplemental Information 7</label>
      <caption>
        <title>Appendix 7.</title>
        <p>GO enrichment analysis of the union of set of genes across 3 conditions (lesional, non-lesion, peri-lesional)</p>
      </caption>
      <media xlink:href="peerj-08-9119-s007.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-8">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-8</object-id>
      <label>Supplemental Information 8</label>
      <caption>
        <title>Appendix 8.</title>
        <p>22 Predicted genes via GeneMania plugin of Cytoscape</p>
      </caption>
      <media xlink:href="peerj-08-9119-s008.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-9">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-9</object-id>
      <label>Supplemental Information 9</label>
      <caption>
        <title>GO Enrichment Results of DEG of Lesional vs. Healthy Condition.</title>
      </caption>
      <media xlink:href="peerj-08-9119-s009.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-10">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-10</object-id>
      <label>Supplemental Information 10</label>
      <caption>
        <title>GO Enrichment Results of DEG of Non-Lesional vs. Healthy Condition.</title>
      </caption>
      <media xlink:href="peerj-08-9119-s010.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-11">
      <object-id pub-id-type="doi">10.7717/peerj.9119/supp-11</object-id>
      <label>Supplemental Information 11</label>
      <caption>
        <title>GO Enrichment Results of DEG of Peri-Lesional vs. Healthy Condition.</title>
      </caption>
      <media xlink:href="peerj-08-9119-s011.csv">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>P.N. and A.S. would like to acknowledge Dr. Ashok K. Chauhan, Founder President, Amity University, Uttar Pradesh for providing us the opportunity to conduct research and innovation. P.S., S.M., A.C., M.T., P.N. and A.S. would like to thank the Centre for Computational Biology and Bioinformatics, Amity Institute of Biotechnology, Amity University for providing them necessary resources. P.S., S.M., A.C. and M.T. would like to specifically acknowledge P.N. and A.S. for introducing the topic of the drug-target interaction network for vitiligo.</p>
  </ack>
  <sec sec-type="additional-information">
    <title>Additional Information and Declarations</title>
    <fn-group content-type="competing-interests">
      <title>Competing Interests</title>
      <fn fn-type="COI-statement" id="conflict-1">
        <p>The authors declare that they have no competing interests. Even though they have made an attempt to cover as much information as possible related to Vitiligo by manual curation and sophisticated bioinformatics approaches, it is possible that a few articles might not be incorporated with their search criteria.</p>
      </fn>
    </fn-group>
    <fn-group content-type="author-contributions">
      <title>Author Contributions</title>
      <fn fn-type="con" id="contribution-1">
        <p><xref ref-type="contrib" rid="author-1">Priyansh Srivastava</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-2">
        <p><xref ref-type="contrib" rid="author-2">Alakto Choudhury</xref> analyzed the data, prepared figures and/or tables, database Development, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-3">
        <p><xref ref-type="contrib" rid="author-3">Mehak Talwar</xref> performed the experiments, prepared figures and/or tables, website Development, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-4">
        <p><xref ref-type="contrib" rid="author-4">Sabyasachi Mohanty</xref> performed the experiments, prepared figures and/or tables, database Development, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-5">
        <p><xref ref-type="contrib" rid="author-5">Priyanka Narad</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-6">
        <p><xref ref-type="contrib" rid="author-6">Abhishek Sengupta</xref> conceived and designed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the paper, and approved the final draft.</p>
      </fn>
    </fn-group>
    <fn-group content-type="other">
      <title>Data Availability</title>
      <fn id="addinfo-1">
        <p>The following information was supplied regarding data availability:</p>
        <p>The analysis results are available as <xref ref-type="supplementary-material" rid="supplemental-information">Supplemental Files</xref>. The database is available at <uri xlink:href="https://vitiligoinfores.com/">https://vitiligoinfores.com/</uri>.</p>
      </fn>
    </fn-group>
  </sec>
  <ref-list content-type="authoryear">
    <title>References</title>
    <ref id="ref-1">
      <label>Bateman et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>El-Hachem</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Beck</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aerts</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Haibe-Kains</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Importance of collection in gene set enrichment analysis of drug response in cancer cell lines</article-title>
        <source>Scientific Reports</source>
        <year>2014</year>
        <volume>4</volume>
        <issue>1</issue>
        <fpage>1675</fpage>
        <pub-id pub-id-type="doi">10.1038/srep04092</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-2">
      <label>Berman (2000)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>The protein data bank</article-title>
        <source>Nucleic Acids Research</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-3">
      <label>Bishnoi &amp; Parsad (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bishnoi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Parsad</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Clinical and molecular aspects of vitiligo treatments</article-title>
        <source>International Journal of Molecular Sciences</source>
        <year>2018</year>
        <volume>19</volume>
        <issue>5</issue>
        <fpage>1509</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms19051509</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-4">
      <label>Boniface et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boniface</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Seneschal</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Picardo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Taïeb</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy</article-title>
        <source>Clinical Reviews in Allergy &amp; Immunology</source>
        <year>2017</year>
        <volume>54</volume>
        <issue>1</issue>
        <fpage>52</fpage>
        <lpage>67</lpage>
        <pub-id pub-id-type="doi">10.1007/s12016-017-8622-7</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-5">
      <label>Clark et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Clark</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Negron</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hauser</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Abel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Friesner</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Relative binding affinity prediction of charge-changing sequence mutations with FEP in protein–protein interfaces</article-title>
        <source>Journal of Molecular Biology</source>
        <year>2019</year>
        <volume>431</volume>
        <issue>7</issue>
        <fpage>1481</fpage>
        <lpage>1493</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmb.2019.02.003</pub-id>
        <pub-id pub-id-type="pmid">30776430</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-6">
      <label>Clough &amp; Barrett (2016)</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Clough</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Barrett</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <person-group person-group-type="editor">
          <name>
            <surname>Mathé</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The gene expression omnibus database</article-title>
        <source>Statistical Genomics. Methods in Molecular Biology</source>
        <year>2016</year>
        <volume>1418</volume>
        <publisher-loc>New York</publisher-loc>
        <publisher-name>Humana Press</publisher-name>
        <fpage>93</fpage>
        <lpage>110</lpage>
      </element-citation>
    </ref>
    <ref id="ref-7">
      <label>Deng et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deng</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Transcriptome analysis and emerging driver identification of CD8+ T cells in patients with vitiligo</article-title>
        <source>Oxidative Medicine and Cellular Longevity</source>
        <year>2019</year>
        <volume>2019</volume>
        <issue>3</issue>
        <fpage>1</fpage>
        <lpage>15</lpage>
        <pub-id pub-id-type="doi">10.1155/2019/2503924</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-8">
      <label>Ezzedine et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ezzedine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Eleftheriadou</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Whitton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Van Geel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Vitiligo</article-title>
        <source>Lancet</source>
        <year>2015</year>
        <volume>386</volume>
        <issue>9988</issue>
        <fpage>74</fpage>
        <lpage>84</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60763-7</pub-id>
        <pub-id pub-id-type="pmid">25596811</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-9">
      <label>Ezzedine &amp; Silverberg (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ezzedine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Silverberg</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>A practical approach to the diagnosis and treatment of vitiligo in children</article-title>
        <source>Pediatrics</source>
        <year>2016</year>
        <volume>138</volume>
        <issue>1</issue>
        <elocation-id>e20154126</elocation-id>
        <pub-id pub-id-type="doi">10.1542/peds.2015-4126</pub-id>
        <pub-id pub-id-type="pmid">27328922</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-10">
      <label>Ge, Jung &amp; Yao (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ge</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>ShinyGO: a graphical gene-set enrichment tool for animals and plants</article-title>
        <source>Bioinformatics. Bioinformatics</source>
        <year>2019</year>
        <volume>36</volume>
        <issue>8</issue>
        <fpage>2628</fpage>
        <lpage>2629</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btz931</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-11">
      <label>Greenwood et al. (2010)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Greenwood</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Calkins</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Shelley</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Towards the comprehensive, rapid, and accurate prediction of the favourable tautomeric states of drug-like molecules in aqueous solution</article-title>
        <source>Journal of Computer-Aided Molecular Design</source>
        <year>2010</year>
        <volume>24</volume>
        <issue>6–7</issue>
        <fpage>591</fpage>
        <lpage>604</lpage>
        <pub-id pub-id-type="doi">10.1007/s10822-010-9349-1</pub-id>
        <pub-id pub-id-type="pmid">20354892</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-12">
      <label>Irwin &amp; Shoichet (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Irwin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shoichet</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>ZINC: a free database of commercially available compounds for virtual screening</article-title>
        <source>ChemInform</source>
        <year>2005</year>
        <volume>36</volume>
        <issue>16</issue>
        <fpage>16215</fpage>
        <pub-id pub-id-type="doi">10.1002/chin.200516215</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-13">
      <label>Jin et al. (2010)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Birlea</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fain</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gowan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Riccardi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Holland</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mailloux</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sufit</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hutton</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Amadi-Myers</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>McCormack</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kemp</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gawkrodger</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Weetman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Picardo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Leone</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Taïeb</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jouary</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ezzedine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Van Geel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lambert</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Overbeck</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Spritz</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo</article-title>
        <source>New England Journal of Medicine</source>
        <year>2010</year>
        <volume>362</volume>
        <issue>18</issue>
        <fpage>1686</fpage>
        <lpage>1697</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa0908547</pub-id>
        <pub-id pub-id-type="pmid">20410501</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-14">
      <label>Kanehisa et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Furumichi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tanabe</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sato</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Morishima</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>KEGG: new perspectives on genomes, pathways, diseases and drugs</article-title>
        <source>Nucleic Acids Research</source>
        <year>2020</year>
        <volume>45</volume>
        <issue>D1</issue>
        <fpage>D353</fpage>
        <lpage>D361</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw1092</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-15">
      <label>Kim et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Thiessen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bolton</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gindulyte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Shoemaker</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bryant</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>PubChem substance and compound databases</article-title>
        <source>Nucleic Acids Research</source>
        <year>2015</year>
        <volume>44</volume>
        <issue>D1</issue>
        <fpage>D1202</fpage>
        <lpage>D1213</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv951</pub-id>
        <pub-id pub-id-type="pmid">26400175</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-16">
      <label>Malhotra et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Malhotra</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jha</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pandey</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Construction of a comprehensive protein-protein interaction map for vitiligo disease to identify key regulatory elements: a systemic approach</article-title>
        <source>Interdisciplinary Sciences: Computational Life Sciences</source>
        <year>2017</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>500</fpage>
        <lpage>514</lpage>
        <pub-id pub-id-type="doi">10.1007/s12539-017-0213-z</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-17">
      <label>Mathur et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mathur</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Prakash</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anand</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Agrawal</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>PEPlife: a repository of the half-life of peptides</article-title>
        <source>Scientific Reports</source>
        <year>2016</year>
        <volume>6</volume>
        <issue>1</issue>
        <fpage>36617</fpage>
        <pub-id pub-id-type="doi">10.1038/srep36617</pub-id>
        <pub-id pub-id-type="pmid">27819351</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-18">
      <label>MATLAB (2019)</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <collab>
            <institution>MATLAB</institution>
          </collab>
        </person-group>
        <source>MATLAB for Artificial Intelligence</source>
        <publisher-loc>Natick</publisher-loc>
        <publisher-name>The MathWorks Inc</publisher-name>
        <year>2019</year>
        <uri xlink:href="https://in.mathworks.com/">https://in.mathworks.com/</uri>
      </element-citation>
    </ref>
    <ref id="ref-19">
      <label>Mering (2003)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mering</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>STRING: a database of predicted functional associations between proteins</article-title>
        <source>Nucleic Acids Research</source>
        <year>2003</year>
        <volume>31</volume>
        <issue>1</issue>
        <fpage>258</fpage>
        <lpage>261</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg034</pub-id>
        <pub-id pub-id-type="pmid">12519996</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-20">
      <label>Mostafavi et al. (2020)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mostafavi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ray</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Warde-Farley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Grouios</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Morris</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>GeneMANIA: a real-time multiple association network integration algorithms for predicting gene function</article-title>
        <source>Genome Biology</source>
        <year>2020</year>
        <volume>9</volume>
        <issue>Suppl. 1</issue>
        <fpage>S4</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2008-9-s1-s4</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-21">
      <label>Motschall &amp; Falck-Ytter (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Motschall</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Falck-Ytter</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Searching the MEDLINE literature database through PubMed: a short guide</article-title>
        <source>Oncology Research and Treatment</source>
        <year>2005</year>
        <volume>28</volume>
        <issue>10</issue>
        <fpage>517</fpage>
        <lpage>522</lpage>
        <pub-id pub-id-type="doi">10.1159/000087186</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-22">
      <label>Regazzetti et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Regazzetti</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Joly</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Marty</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rivier</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mehul</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Reiniche</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mounier</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rival</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Piwnica</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cavalié</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chignon-Sicard</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ballotti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Voegel</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Passeron</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients</article-title>
        <source>Journal of Investigative Dermatology</source>
        <year>2015</year>
        <volume>135</volume>
        <issue>12</issue>
        <fpage>3105</fpage>
        <lpage>3114</lpage>
        <pub-id pub-id-type="doi">10.1038/jid.2015.335</pub-id>
        <pub-id pub-id-type="pmid">26322948</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-23">
      <label>Rodrigues et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ezzedine</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hamzavi</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pandya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>New discoveries in the pathogenesis and classification of vitiligo</article-title>
        <source>Journal of the American Academy of Dermatology</source>
        <year>2017</year>
        <volume>77</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jaad.2016.10.048</pub-id>
        <pub-id pub-id-type="pmid">28619550</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-24">
      <label>Safran et al. (2010)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Safran</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dalah</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Alexander</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rosen</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Iny Stein</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shmoish</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nativ</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Bahir</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Doniger</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Krug</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sirota-Madi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Olender</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Golan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Stelzer</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Harel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lancet</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>GeneCards Version 3: the human gene integrator</article-title>
        <source>Database</source>
        <year>2010</year>
        <volume>2010</volume>
        <fpage>baq020</fpage>
        <pub-id pub-id-type="doi">10.1093/database/baq020</pub-id>
        <pub-id pub-id-type="pmid">20689021</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-25">
      <label>Salinas-Santander et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Salinas-Santander</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Trevino</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>De La Rosa-Moreno</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Verduzco-Garza</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sinchez-Dominguez</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Canti-Salinas</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ocampo-Garza</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lagos-Rodriguez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ocampo-Candiani</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ortiz-Lipez</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>CAPN3, DCT, MLANA and TYRP1 are overexpressed in skin of vitiligo vulgaris Mexican patients</article-title>
        <source>Experimental and Therapeutic Medicine</source>
        <year>2018</year>
        <volume>15</volume>
        <issue>3</issue>
        <fpage>2804</fpage>
        <lpage>2811</lpage>
        <pub-id pub-id-type="pmid">29456684</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-26">
      <label>Schrödinger (2020)</label>
      <element-citation publication-type="other">
        <person-group person-group-type="author">
          <collab>
            <institution>Schrödinger</institution>
          </collab>
        </person-group>
        <article-title>Schrödinger Suite</article-title>
        <year>2020</year>
        <uri xlink:href="http://www.schrodinger.com">http://www.schrodinger.com</uri>
      </element-citation>
    </ref>
    <ref id="ref-27">
      <label>Shannon (2003)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shannon</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>
        <source>Genome Research</source>
        <year>2003</year>
        <volume>13</volume>
        <issue>11</issue>
        <fpage>2498</fpage>
        <lpage>2504</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
        <pub-id pub-id-type="pmid">14597658</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-28">
      <label>Srivastava, Pal &amp; Misra (2018)</label>
      <element-citation publication-type="confproc">
        <person-group person-group-type="author">
          <name>
            <surname>Srivastava</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Misra</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Comparative modelling and virtual screening to discover potential competitive inhibitors targeting the 30s ribosomal subunit S2 and S9 in Acinetobacter baumannii</article-title>
        <year>2018</year>
        <conf-name>2018 International Conference on Bioinformatics and Systems Biology (BSB)</conf-name>
        <conf-date>26–28 October 2018</conf-date>
        <conf-loc>Allahabad, India</conf-loc>
      </element-citation>
    </ref>
    <ref id="ref-29">
      <label>Storey &amp; Tibshirani (2003)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Storey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tibshirani</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Statistical significance for genomewide studies</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year>2003</year>
        <volume>100</volume>
        <issue>16</issue>
        <fpage>9440</fpage>
        <lpage>9445</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1530509100</pub-id>
        <pub-id pub-id-type="pmid">12883005</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-30">
      <label>Sun et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Rabbani</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Takeo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Noel</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Taketo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Myung</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Millar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Dissecting Wnt signaling for melanocyte regulation during wound healing</article-title>
        <source>Journal of Investigative Dermatology</source>
        <year>2018</year>
        <volume>138</volume>
        <issue>7</issue>
        <fpage>1591</fpage>
        <lpage>1600</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jid.2018.01.030</pub-id>
        <pub-id pub-id-type="pmid">29428355</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-31">
      <label>Sweere &amp; Fraaije (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sweere</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fraaije</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Accuracy test of the OPLS-AA force field for calculating free energies of mixing and comparison with PAC-MAC</article-title>
        <source>Journal of Chemical Theory and Computation</source>
        <year>2017</year>
        <volume>13</volume>
        <issue>5</issue>
        <fpage>1911</fpage>
        <lpage>1923</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jctc.6b01106</pub-id>
        <pub-id pub-id-type="pmid">28418655</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-32">
      <label>Takeo et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Takeo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Rabbani</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Manga</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>EdnrB governs regenerative response of melanocyte stem cells by crosstalk with Wnt signaling</article-title>
        <source>Cell Reports</source>
        <year>2016</year>
        <volume>15</volume>
        <issue>6</issue>
        <fpage>1291</fpage>
        <lpage>1302</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2016.04.006</pub-id>
        <pub-id pub-id-type="pmid">27134165</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-33">
      <label>Tarlé et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tarlé</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nascimento</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Mira</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Castro</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Vitiligo: part 1</article-title>
        <source>Anais Brasileiros de Dermatologia</source>
        <year>2014</year>
        <volume>89</volume>
        <issue>3</issue>
        <fpage>461</fpage>
        <lpage>470</lpage>
        <pub-id pub-id-type="doi">10.1590/abd1806-4841.20142573</pub-id>
        <pub-id pub-id-type="pmid">24937821</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-34">
      <label>The Gene Ontology Consortium (2007)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>
            <institution>The Gene Ontology Consortium</institution>
          </collab>
        </person-group>
        <article-title>The Gene Ontology project in 2008</article-title>
        <source>Nucleic Acids Research</source>
        <year>2007</year>
        <volume>36</volume>
        <issue>1</issue>
        <fpage>D440</fpage>
        <lpage>D444</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkm883</pub-id>
        <pub-id pub-id-type="pmid">17984083</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-35">
      <label>The UniProt Consortium (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>
            <institution>The UniProt Consortium</institution>
          </collab>
        </person-group>
        <article-title>UniProt: the universal protein knowledge base</article-title>
        <source>Nucleic Acids Research</source>
        <year>2016</year>
        <volume>45</volume>
        <issue>1</issue>
        <fpage>D158</fpage>
        <lpage>D169</lpage>
        <pub-id pub-id-type="pmid">27899622</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-36">
      <label>Wang, Li &amp; Li (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Perspectives of new advances in the pathogenesis of vitiligo: from oxidative stress to autoimmunity</article-title>
        <source>Medical Science Monitor</source>
        <year>2019</year>
        <volume>25</volume>
        <fpage>1017</fpage>
        <lpage>1023</lpage>
        <pub-id pub-id-type="doi">10.12659/MSM.914898</pub-id>
        <pub-id pub-id-type="pmid">30723188</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-37">
      <label>Wishart et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wishart</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Feunang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Marcu</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sajed</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sayeeda</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Assempour</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Iynkkaran</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Maciejewski</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gale</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cummings</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Le</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Knox</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>
        <source>Nucleic Acids Research</source>
        <year>2017</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1074</fpage>
        <lpage>D1082</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-38">
      <label>Wlodawer et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wlodawer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Minor</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Dauter</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jaskolski</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Protein crystallography for aspiring crystallographers or how to avoid pitfalls and traps in macromolecular structure determination</article-title>
        <source>FEBS Journal</source>
        <year>2013</year>
        <volume>280</volume>
        <issue>22</issue>
        <fpage>5705</fpage>
        <lpage>5736</lpage>
        <pub-id pub-id-type="doi">10.1111/febs.12495</pub-id>
        <pub-id pub-id-type="pmid">24034303</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-39">
      <label>Wu et al. (2004)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Irizarry</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gentleman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Martinez-Murillo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Spencer</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>A model-based background adjustment for oligonucleotide expression arrays</article-title>
        <source>Journal of the American Statistical Association</source>
        <year>2004</year>
        <volume>99</volume>
        <issue>468</issue>
        <fpage>909</fpage>
        <lpage>917</lpage>
        <pub-id pub-id-type="doi">10.1198/016214504000000683</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-40">
      <label>Yamada et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yamada</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hasegawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Date</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mizutani</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakata</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matsunaga</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Akamatsu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Wnt/β-Catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation</article-title>
        <source>Journal of Investigative Dermatology</source>
        <year>2013</year>
        <volume>133</volume>
        <issue>12</issue>
        <fpage>2753</fpage>
        <lpage>2762</lpage>
        <pub-id pub-id-type="doi">10.1038/jid.2013.235</pub-id>
        <pub-id pub-id-type="pmid">23702581</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-41">
      <label>Zeng et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>NPASS: natural product activity and species source database for natural product research, discovery and tool development</article-title>
        <source>Nucleic Acids Research</source>
        <year>2017</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D1217</fpage>
        <lpage>D1222</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1026</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-42">
      <label>Zhang et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>The prevalence of vitiligo: a meta-analysis</article-title>
        <source>PLOS ONE</source>
        <year>2016</year>
        <volume>11</volume>
        <issue>9</issue>
        <elocation-id>e0163806</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0163806</pub-id>
        <pub-id pub-id-type="pmid">27673680</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
